Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

The post is in association with a Tutorial Fellowship at Exeter College.

I am delighted to announce that Associate Professor Neil Herring has been appointed to the APTF in association with Exeter College. Neil undertook his medical training in Oxford and completed his DPhil in the department. He is an Honorary Consultant Physician in Cardiovascular Medicine and was recently made a Fellow of The Royal College of Physicians. He will continue to undertake some clinical duties, but his research will be based in the department. - Head of Department, Professor David Paterson

NeilherringAPTFnewsembed.jpgA heart attack is caused when the blood supply to the heart becomes blocked. Many people still die from this condition owing to life-threatening heart rhythms or heart failure causing a weakened heart. After 50 years of research, beta-blockers are the only type of drug we have found that prolongs life after a heart attack by preventing dangerous heart rhythms. These drugs target norepinephrine, a chemical that can trigger dangerous heart rhythms when the heart is damaged. Norepinephrine is a type of “neurotransmitter” - chemicals released by a specific group of nerves.  

Associate Professor Neil Herring's research group, funded by the British Heart Foundation, has discovered that the same group of nerves also release a neurotransmitter called neuropeptide-Y (NPY), and that levels of NPY within the heart are very high following a heart attack and during heart failure. Prof Herring and his team has shown that NPY can trigger dangerous heart rhythms and worsen heart failure by further restricting the heart’s blood supply. 

Associate Professor Neil Herring said: "The goal of our ongoing research is two-fold: to discover whether standard blood samples taken from veins to measure NPY can help doctors identify patients at highest risk of death, and to better understand the role that NPY plays in controlling the heart, blood vessels and nerves so that drugs can be made to combat its actions."

Over the summer, a major new study led by Prof Herring established a new approach to reducing damage after a heart attack. It was published in a paper entitled Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction in the European Heart Journal. 

The department would like to congratulate Prof Herring on his appointment as Associate Professor in Cardiovascular Physiology and Tutorial Fellow at Exeter College.

Similar stories

Winners of DPAG Image Competition announced

A department-wide image competition has yielded a range of stunning images showcasing the diversity and breadth of DPAG's science. Three prize winners and eight commended pictures are announced.

Christoph Treiber awarded ERC Starting Grant to investigate the origins of behavioural diversity

Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.

Enriching Engagement grant set to transform public understanding of the human form

A Srinivas Group-led collaborative public engagement project has been awarded more than £188k to bring a multi-disciplinary approach to the concepts of ‘destiny’ and ‘embodiment’ to the local Oxford community.

Eminent neuroscientist Randy Bruno Joins DPAG

This week, Randy Bruno, PhD starts his research group here at DPAG. He joins the Department as Professor of Neuroscience and Tutorial Fellow at St Peter’s College. He was previously an Associate Professor of Neuroscience at Columbia University, Principal Investigator at Columbia’s Mortimer B. Zuckerman Mind Brain Behavior Institute, and a member of the Kavli Institute for Brain Science.